El espectro clínico y de laboratorio de la enfermedad de Alzheimer
una perspectiva neurológica
DOI:
https://doi.org/10.34019/1982-1247.2020.v14.30649Palabras clave:
Demencia, Enfermedad de Alzheimer, Neurologia, MedicinaResumen
Esta revisión narrativa de la literatura tiene como objetivo mostrar los cambios recientes relacionados con el diagnóstico de la enfermedad de Alzheimer (EA). El diagnóstico es clínico, sin embargo, existe una creciente comprensión de que los biomarcadores en el líquido cefalorraquídeo y neuroimagen molecular pueden desempeñar un papel importante en la definición etiopatogénica. Los biomarcadores pueden ser importantes para el diagnóstico en las primeras etapas de la EA. Reconociendo que la EA es un proceso fisiopatológico cerebral, la presencia de biomarcadores indica EA. Actualmente, el uso de biomarcadores está dirigido a la investigación clínica y al desarrollo de nuevos fármacos.
Descargas
Citas
Albert, M.S., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H. Fox, N.C., Gamst, A., … & Phelps, C.H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 270-9. https://dx.doi.org/10.1016/j.jalz.2011.03.008
Alzheimer’s Association (AA). (2020). 2020 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia, 16, 3Goldman, J.S., Hahn, S.E., Catania, J.W., LaRusse-Eckert, S., Butson, M.B., Rumbaugh, M., Strecker, M.N., … & Bird, T. (2011). Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in Medicine, 13, 597-605. https://dx.doi.org/10.1097/GIM.0b013e31821d69b8
Grande, G., Vanacore, N., Maggiore, L., Cucumo, V., Ghiretti, R., Galimberti, D., Scarpini, E., Mariani, C. & Clerici, F. (2014). Physical activity reduces the risk of dementia in mild cognitive impairment subjects: a cohort study. Journal of Alzheimer's disease, 39(4), 833-839. https://dx.doi.org/10.3233/JAD-131808
Hall, S., Ohrfelt, A., Constantinescu, R., Andreasson, U., Surova, Y., Bostrom, F., Nilsson, C., … & Hansson, O. (2012). Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders. Archives of Neurology, 69(11), 1445-52. https://dx.doi.org/10.1001/archneurol.2012.1654
Hebert, L.E., Weuve, J., Scherr, P.A., & Evans, D.A. (2013). Alzheimer disease in the united states (2010-2050) estimated using the 2010 census. Neurology, 80, 1778-1783. https://dx.doi.org/10.1212/WNL.0b013e31828726f5
Hyman, B.T., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Carrillo, M.C., Dickson, D.W., … & Montine, T.J. (2012). National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimer’s & Dementia, 8, 1–13. https://dx.doi.org/10.1016/j.jalz.2011.10.007
Ikonomovic, M.D., Klunk, W., Abrahamson, E.E., Mathis, C.A., Price, J.C., Tsopelas, N.D., Lopresti, B.J., … & DeKosky, S.T. (2008). Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain, 131 (Pt 6), 1630-45. https://dx.doi.org/10.1093/brain/awn016
Kales, H.C., Chen, P., Blow, F.C., Welsh, D.E., & Mellow, A.M. (2005). Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression. The American Journal of Geriatric Psychiatry, 13(6), 441–9. https://dx.doi.org/10.1176/appi.ajgp.13.6.441
Knopman, D.S., Haeberlein, S.B., Carrillo, M.C., Hendrix, J.A., Kerchner, G., Margolin, R., Maruff, P., … & Siemers, E. (2018). The National Institute on Aging and the Alzheimer’s Association Research Framework for Alzheimer’s disease: Perspectives from the Research Roundtable. Alzheimer’s & Dementia, 14, 563-575. https://dx.doi.org/10.1016/j.jalz.2018.03.002
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S.G., Huntley, J., Ames, D., Ballard, C., … & Mukadam, N. (2017). Dementia prevention, intervention, and care. Lancet (London, England), 390(10113), 2673-734. https://dx.doi.org/10.1016/S0140-6736(17)31363-6
Loy, C.T., Schofield, P.R., Turner, A.M., & Kwok, J.B. (2014). Genetics of dementia. Lancet (London, England), 383, 828–40. https://dx.doi.org/10.1016/S0140-6736(13)60630-3
Mattsson, N., Zetterberg, H., Hansson, O., Andreasen, N., Parnetti, L., Jonsson, M., Herukka, S.K., … & Blennow, K. (2009). CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA, 302(4), 385-93. https://dx.doi.org/10.1001/jama.2009.1064
Mayer, F., Di Pucchio, A., Lacorte, E., Bacigalupo, I., Marzolini, F., Ferrante, G., Minardi, V., ... & Vanacore, N. (2018). An estimate of attributable cases of Alzheimer disease and vascular dementia due to modifiable risk factors: the impact of primary prevention in Europe and in Italy. Dementia and Geriatric Cognitive Disorders Extra, 8(1), 60-71. https://dx.doi.org/10.1159/000487079
McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr., Kawas, C.H., Klunk, W.E., … & Phelps, C.H. (2011). The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia,7(3):263-9. https://dx.doi.org/10.1016/j.jalz.2011.03.005
Mendez, M.F. (2017). Early-onset Alzheimer disease. Neurologic Clinics, 35, 263-281. https://dx.doi.org/10.1016/j.ncl.2017.01.005
Mitchell, A.J., & Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia: Meta-analysis of 41 robust inception cohort
studies. Acta Psychiatrica Scandinavica, 119(4), 252-65. https://dx.doi.org/10.1111/j.1600-0447.2008.01326.x
Molinuevo, J.L., Blennow, K., Dubois, B., Engelborghs, S., Lewczuk, P., Perret-Liaudet, A., Teunissen, C.E., & Parnetti, L. (2014). The clinical use of cerebrospinal fluid biomarker testing for Alzheimer’s disease diagnosis: a consensus paper from the Alzheimer’s Biomarkers Standardization Initiative. Alzheimer’s & Dementia, 10(6), 808-17. https://dx.doi.org/10.1016/j.jalz.2014.03.003
Moreira, S.V., Justi, F.R.R., & Moreira, M. (2018). Can musical intervention improve memory in Alzheimer’s patients? Evidence from a systematic review. Dementia & Neuropsychologia, 12, 133-42. https://dx.doi.org/10.1590/1980-57642018dn12-020005
Nasreddine, Z.S., Phillips, N.A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J.L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of The American Geriatrics Society, 53(4), 695-9. https://dx.doi.org/10.1111/j.1532-5415.2005.53221.x
Okello, A., Koivunen, J., Edison, P., Archer, H.A., Turkheimer, F.E., Nagren, K., Bullock, R., … & Brooks, D.J. (2009). Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology, 73(10), 754-60. https://dx.doi.org/10.1212/WNL.0b013e3181b23564
Okura, T., Plassman, B.L., Steffens, D.C., Llewellyn, D.J., Potter, G.G., & Langa, K.M. (2011). Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. Journal of the American Geriatrics Society, 59(3), 473–81. https://dx.doi.org/10.1111/j.1532-5415.2011.03314.x
Ossenkoppele, R., Pijnenburg, Y.A., Perry, D.C., Cohn-Sheehy, B.I., Scheltens, N.M., Vogel, J.W., Kramer, J.H., … & Rabinovici, G.D. (2015). The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain, 138(Pt 9), 2732-49. https://dx.doi.org/10.1093/brain/awv191
Pais, M., Martinez, L., Ribeiro, O., Loureiro, J., Fernandez, R., Valiengo, L., Canineu, P., ... & Forlenza, O.V. (2020). Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges. Brazilian Journal of Psychiatry, Jan 24. pii: S1516-44462020005001205. https://dx.doi.org/10.1590/1516-4446-2019-0735 [Epub ahead of print]
